2008 Summer Meeting - Leeds - The Pathological Society of Great ...

Detailed Programme – Tuesday 1 July 2008Presenter = {P} · Abstract numbers are shown in bold and square brackets eg [S123]10.00 Sports Hall 1REGISTRATION and COFFEE11.00–17.00 Sports Hall BalconySLIDE SEMINAR CASE VIEWING: Soft TissueCases submitted by Dr W Merchant, Department of Histopathology and MolecularPathology, St James’s Institute of Oncology11.00–11.15 Conference Auditorium 1WELCOME ADDRESSDr H Grabsch, University of Leeds11.15–13.00 Conference Auditorium 1SYMPOSIUM: Pathology informaticsChair: Dr H Grabsch, University of LeedsDr D Treanor, University of Leeds11.15–11.45 [S1] Virtual slides in research and diagnosisDr D Treanor, University of Leeds11.45–12.15 [S2] NCRI/NCI Bioinformatics initiativeDr S Bell, National Cancer Research Institute, Informatics Initiative, London12.15–13.00 KEYNOTE LECTURE:[S3] A human protein atlasProf F Ponten, Department of Genetics and Pathology, Uppsala UniversityHospital, Uppsala, Sweden13.00–14.00 Sports Hall 1LUNCHPOSTER VIEWING and TRADE EXHIBITION14.00–17.00 Conference Auditorium 1ORAL COMMUNICATIONS: BreastChair: Prof LB Jones, Queen Mary’s School of Medicine and Dentistry, LondonDr A Shaaban, St James’s Institute of Oncology, Leeds14.00–14.15 [O1] FABP7 Expression predicts better outcome in basal-like breast cancer{P} H Zhang, EA Rakha, GR Ball, EC Paish, C Caldas, IO Ellis, AR Green14.15–14.30 [O2] Tiling path genomic profiling of grade III invasive ductal breast carcinomas{P} R Natrajan, SM Rodriguez-Pinilla, C Marchio, R Vatcheva, MB Lambros,LG Fulford, A Grigoriadis, A Mackay, K Fenwick, N Tamber, D Hungermann,J Palacios, H Buerger, A Ashworth, JS Reis-Filho14.30–14.45 [O3] Downregulation of 15-hydroxyprostaglandin dehydrogenase contributes totamoxifen resistance in breast cancer{P} M Cummings, L Maraqa, MB Peter, V SpeirsSummer Meeting (194 th ) 1–4 July 2008 Scientific Programme11